U.S. Markets close in 50 mins

Viatris Inc. (VTRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.84-0.07 (-0.50%)
As of 3:10PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.91
Open13.76
Bid13.89 x 1100
Ask13.90 x 2200
Day's Range13.68 - 14.05
52 Week Range12.75 - 19.24
Volume7,967,222
Avg. Volume11,997,586
Market Cap16.706B
Beta (5Y Monthly)1.56
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 27, 2007
1y Target EstN/A
  • Viatris Stock Sacrifices A Breakout As 2021 Guidance Falls Short
    Investor's Business Daily

    Viatris Stock Sacrifices A Breakout As 2021 Guidance Falls Short

    Generic-drug maker Viatris initiated a dividend on Monday, but VTRS stock plummeted after the company issued a downbeat 2021 outlook. Viatris is a combination of Pfizer's Upjohn and Mylan.

  • MarketWatch

    Viatris stock tumbles to pace S&P 500 losers after downbeat revenue, free cash flow outlooks

    Shares of Viatris Inc. tumbled 11.0% in premarket trading, to pace all of the S&P 500's decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, while saying it was initiating a dividend. The company, formed in November through the combination of Mylan and Pfizer Inc.'s Upjohn business, said it expects 2021 revenue of $17.2 billion to $17.8 billion, compared with the FactSet consensus of $18.36 billion. Free cash flow is expected to be $2.0 billion to $2.3 billion, below the FactSet consensus of $3.78 billion. "We are confident that our financial guidance for 2021 is the right starting point for Viatris and continue to expect 2021 to be our trough year in terms of revenue, adjusted EBITDA and free cash flow, reflecting a balanced view of both near-term tailwinds and headwinds, particularly given the delay in closing of the combination between Mylan and Pfizer's Upjohn business," said Viatris Chief Executive Michael Goettler. The company said it was initiating an annualized dividend of 44 cents a share, with the first quarterly dividend of 11 cents a share to be distributed in June.

  • Billionaire Ken Fisher’s 10 New Stock Picks
    Insider Monkey

    Billionaire Ken Fisher’s 10 New Stock Picks

    In this article, we discussed billionaire Ken Fisher’s 10 new stock picks to see how these stocks performed so far in 2021. Click to skip ahead and see Billionaire Ken Fisher’s 5 New Stock Picks. Kenneth Fisher is an American billionaire and hedge fund manager. His total worth stands at $4.3 billion. In a latest […]